GlassScriptPhysician profile
Jonathan Glover Seavey
NPI 1417219510
$3,099.17
in general payments reported to CMS, 2019-2025
13 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,568 · 2022: $240 · 2023: $595 · 2024: $565 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.62 |
| Education | $208.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $1,567.51 | 2021 | |
| Si-Bone, INC. | $264.17 | 2024-2025 | |
| Nuvasive, INC. | $232.52 | 2022-2023 | Xlif, X-Core, Tlif |
| Zimvie INC. | $208.61 | 2023 | |
| Centinel Spine, LLC | $186.38 | 2023-2024 | Prodisc L, Prodisc C Vivo |
| Globus Medical, INC. | $174.86 | 2023 | Excelsiusgps Robotic Navigation System |
| Intrinsic Therapeutics | $150.00 | 2024 | Barricaid Acd (Annular Closure Device) |
| Seaspine Orthopedics Corporation | $103.86 | 2022 | |
| Carlsmed, INC. | $69.15 | 2023 | Aprevo |
| Orthofix Medical, INC. | $63.12 | 2025 | Lattus |
| Neo Spine USA, INC. | $33.65 | 2024 | Neo Pedicle Screw System |
| Elevate Surgical Co | $29.35 | 2024 | |
| Painteq LLC | $15.99 | 2023 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Seavey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.